The estimated Net Worth of David Phillips is at least $625 mil dollars as of 12 January 2022. Mr. Phillips owns over 7,500 units of Meridian Bioscience stock worth over $477,109 and over the last 22 years he sold VIVO stock worth over $0. In addition, he makes $148,167 as Independent Chairman of the Board at Meridian Bioscience.
Sign up
Mr. Phillips VIVO stock SEC Form 4 insiders trading
David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.
The largest trade he's ever made was buying 10,000 units of Meridian Bioscience stock on 12 November 2019 worth over $80,600. On average, David trades about 990 units every 66 days since 2003. As of 12 January 2022 he still owns at least 14,045 units of Meridian Bioscience stock.
You can see the complete history of Mr. Phillips stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Phillips biography
David C. Phillips CPA serves as Independent Chairman of the Board of the Company. Mr. Phillips spent 32 years with Arthur Andersen LLP. His service with this firm included several managing partner leadership positions. After retiring from Arthur Andersen in 1994, Mr. Phillips became Chief Executive Officer of Downtown Cincinnati, Inc., which is responsible for economic revitalization of Downtown Cincinnati. Mr. Phillips retired from DCI in 1999 to devote full time to Cincinnati Works, Inc., an organization dedicated to reducing the number of people living below the poverty level by assisting them to strive towards self-sufficiency through work, and his financial consulting services. Mr. Phillips has also served as a director of Cintas Corporation, retiring in 2012, and as a director of Summit Mutual Funds, a registered investment company, through 2009. The Board believes that the Company benefits greatly from Mr. Phillips’ public accounting experience in dealing with
What is the salary of David Phillips?
As the Independent Chairman of the Board of Meridian Bioscience, the total compensation of David Phillips at Meridian Bioscience is $148,167. There are 6 executives at Meridian Bioscience getting paid more, with John P. Kenny having the highest compensation of $1,508,705.
How old is David Phillips?
David Phillips is 81, he's been the Independent Chairman of the Board of Meridian Bioscience since 2018. There are no older and 13 younger executives at Meridian Bioscience.
What's David Phillips's mailing address?
David's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.
Insiders trading at Meridian Bioscience
Over the last 22 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny y John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of $424,761. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth $173,230.
What does Meridian Bioscience do?
Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
What does Meridian Bioscience's logo look like?
Complete history of Mr. Phillips stock trades at Cintas y Meridian Bioscience
Meridian Bioscience executives and stock owners
Meridian Bioscience executives and other stock owners filed with the SEC include:
-
John P. Kenny,
Pres, CEO & Director -
John Kenny,
Chief Executive Officer, Director -
Lourdes Weltzien,
Executive Vice President - Life Science -
Dr. Lourdes G. Weltzien Ph.D.,
Exec. VP of Life Science Bus. Unit -
Tony Serafini-Lamanna,
Exec. VP of Diagnostics -
Bryan Baldasare,
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller, Treasurer -
David Phillips,
Independent Chairman of the Board -
James Anderson,
Independent Director -
Dwight Ellingwood,
Independent Director -
Felicia Williams,
Independent Director -
Catherine Sazdanoff,
Independent Director -
John Rice,
Independent Director -
John McIlwraith,
Independent Director -
Anthony Bihl,
Independent Director -
Melissa A. Lueke,
Consultant -
Susan D. Rolih,
Consultant -
Melissa J. McCarey,
VP of Global HR -
Charles Wood,
VP of Investor Relations -
Jeff Pinkston,
Director of Corp. Fin. -
Julie Smith,
Sr. VP, Controller & Principal Accounting Officer -
Michael C. Shaughnessy,
EVP, Pres Meridian Global Dx -
Amy Winslow,
EVP, Pres & CEO of Magellan -
Melissa Lueke,
Exec VP, CFO -
Marco G. Calzavara,
Pres & Managing Director, MBE -
Vecheslav A Elagin,
Sr VP, Research & Development -
Eric S. Rasmussen,
EVP, Bus. Development/Strategy -
Kenneth Kozak,
Vice President -
Susan Rolih,
EVP, Reg & Quality Systems -
Lawrence Baldini,
VP, Operations -
Robert J Ready,
Director -
Marviette D. Johnson,
VP, Human Resources -
Todd W Motto,
VP, Sales and Marketing -
Grady Barnes,
VP, Research & Development -
Gregory S Ballish,
VP, Sales and Marketing -
James Buzard,
Director -
Richard Eberly,
Ex. VP, Gen Mgr. Mer. Life Sci -
Gary P Kreider,
Director -
Vivo Family Limited Partner...,
10% owner -
William J Motto,
Chairman, CEO -
Antonio Interno,
Senior Vice President -
John A Kraeutler,
Chairman and CEO -
Tony Serafini Lamanna,
Executive VP-Diagnostics